[Modern aspects of the combined treatment of pulmonary tuberculosis in adolescents].
The paper presents the follow-up data on 171 adolescents with active pulmonary tuberculosis. Extensive, complicated processes were encountered in 30% of patients. Chemotherapy was used in relation to the severity of disease, to the presence of decay and bacterial isolation, to the sensitivity of Mycobacteria tuberculosis. Most patients received routine treatment regimens including four (n = 66) or three (n = 51) drugs. The treatment involved auxiliary drugs (tarivid, protionamid, amykacin). Pathogenetic treatments (lidase therapy, laser blood radiation, magnetic therapy) were employed. Comorbidity was also treated. Good results were achieved in 95.4% of patients. Hospital treatment decreased by 1.5-3 months.
Firsova
V A
VA
Rusakova
L I
LI
Gubkina
M F
MF
Ryzhova
A P
AP
Panova
L V
LV
Kobulashvili
M G
MG
Poluéktova
F G
FG
Iatskova
T V
TV
D000293:Adolescent; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D007834:Lasers; D008280:Magnetics; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000628:therapy*
D000995:Antitubercular Agents; C001543:lidase; D006821:Hyaluronoglucosaminidase
Sovremennye aspekty kompleksnogo lecheniia tuberkuleza legkikh u podrostkov.